CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities:
Net loss	$ (11,047)	$ (14,978)	$ (15,123)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	57,254	60,809	59,542
Amortization of debt issuance costs	1,282	1,196	1,219
Amortization of acquired market leases, net	(357)	72	(2,323)
Amortization of equity-based compensation	130	102	88
Reduction in the carrying amount of the right-of-use asset	367	386	408
Straight-line income, net	(2,330)	(1,063)	(1,091)
Other non-cash adjustments	218	201	184
Changes in assets and liabilities:
Accounts payable and accrued expenses	1,357	(1,337)	957
Accounts and rent receivable	(1,160)	1,353	(2,440)
Other assets	(3,174)	(2,214)	(2,477)
Due to related parties	82	(105)	(1,267)
Operating lease liability	312	294	276
Other liabilities	(237)	(1,424)	1,448
Net cash flows provided by operating activities	42,697	43,292	39,401
Cash flows from investing activities:
Capital expenditures	(22,031)	(13,908)	(10,351)
Net cash flows used in investing activities	(22,031)	(13,908)	(10,351)
Cash flows from financing activities:
Payment of credit facility	(162,986)	(11,000)	(12,576)
Proceeds from credit facility	285,986	2,000	44,576
Payment of mortgages payable	(118,952)	(340)	(41,674)
Proceeds from the distribution reinvestment plan		5,001	6,976
Shares repurchased		(5,001)	(5,966)
Distributions paid	(19,590)	(19,602)	(19,636)
Payment of debt issuance costs	(3,601)
Early termination of interest rate swap agreements, net			370
Net cash flows used in financing activities	(19,143)	(28,942)	(27,930)
Net increase in cash, cash equivalents and restricted cash	1,523	442	1,120
Cash, cash equivalents and restricted cash, at beginning of the year	6,896	6,454	5,334
Cash, cash equivalents and restricted cash, at end of the year	8,419	6,896	6,454
Supplemental disclosure of cash flow information:
Cash paid for interest	38,832	40,935	40,397
Supplemental schedule of non-cash investing and financing activities:
Accrued capital expenditures	$ 1,632	$ 3,581	$ 1,080